USD 7.0
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 353.86 Thousand USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2009 | 2.74 Million USD | 118.28% |
2008 | 1.25 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q4 | 353.86 Thousand USD | 15.17% |
2023 Q2 | 263.1 Thousand USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q3 | 307.25 Thousand USD | 16.78% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2010 Q2 | 3.79 Million USD | 53.24% |
2010 Q1 | 2.47 Million USD | 2212377.32% |
2009 Q4 | 111.89 USD | 0.0% |
2009 FY | 2.74 Million USD | 118.28% |
2008 FY | 1.25 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
America Great Health | 1.87 Million USD | 81.079% |
Gene Biotherapeutics, Inc. | - USD | -Infinity% |
Evolutionary Genomics, Inc. | 3.74 Million USD | 90.548% |
Innovation1 Biotech Inc. | 228.99 Thousand USD | -54.528% |
Point of Care Nano-Technology, Inc. | - USD | -Infinity% |